LIVN Q4 2024 Earnings — LivaNova PLC Revenue & Financial Results | Market Cap Arena

LIVNLivaNova PLC

$3B

Q4 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$322M+3.8% YoY

Gross Profit

$219M68.2% margin

Operating Income

$37M11.5% margin

Net Income

$56M17.4% margin

EPS (Diluted)

$1.02

QoQ Revenue Growth

+1.2%

Cash Flow

Operating Cash Flow

$79M

Free Cash Flow

$68M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$2.5B

Total Liabilities

$1.2B

Stockholders' Equity

$1.3B

Cash & Equivalents

$429M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$322M	$310M	+3.8%
Gross Profit	$219M	$190M	+15.3%
Operating Income	$37M	-$88M	+142.1%
Net Income	$56M	$16M	+242.1%

Revenue Segments

Cardiopulmonary Segment

$182M57%

Neuromodulation Segment

$138M43%

Geographic Segments

UNITED STATES

$175M54%

Locations Excluding The United States And Europe

$85M26%

Europe

$62M19%